Stem cell research reducing need for insulin
A JDRF-funded clinical trial by researchers in America and China has used stem cells from umbilical cord blood to ‘re-educate’ the immune cells that cause type 1 diabetes.
By targeting the autoimmune response that attacks beta cells in type 1 diabetes, researchers aimed to improve beta cell function in people with the disease and enable them to resume insulin production.
6 Comments 
If you’ve been following us on
Did you know about the changes to Australian Government private health insurance legislation?
JDRF-funded Australian researchers have identified a simple cellular compound that may be able to prevent onset of type 1 diabetes by preventing or reducing the death of insulin-producing cells.
Bambi Northwood-Blyth is flying the flag for Australians with type 1 diabetes making it big on the world stage. Bambi has recently modelled for large Europe fashion houses like Balenciaga and Chanel, and has been the cover girl for magazines like Harper’s Bazaar.
This essential work of JDRF is now supported by a new logo, which will be adopted by JDRF chapters across the world. This new logo better demonstrates our energetic dedication to a better life for people with T1D and, ultimately a cure.
With one month to go until the
Julie Burong’s son Luke was diagnosed on Boxing Day 2005 – his mature approach and acceptance of finger pricks, carb counting and insulin injections as a way of life has inspired Julie to raise funds and awareness of type 1 diabetes.
The JDRF community has helped us to support more than 60 Australian research projects in 2011. These projects have one important thing in common – they are all helping move us closer to a better life and a cure for people with type 1 diabetes.



